Inventor · disambiguated record
Guangxin Xia
Also filed as: XIA GUANGXIN
11 granted patents·17 pending applications·10 citations·filing 2005–2023
82Inventor score
Files withSHANGHAI PHARMACEUTICALS HOLDING CO LTD22MITSUBISHI TANABE PHARMA CORP2AKATSUKA HIDENORI1CHEMAGIS LTD1IIJIMA TORU1
Top patents by PatentIndex Score
28 records- 0175US8975252B2Morpholine derivativeAKATSUKA HIDENORI·Filed 2008·Granted Mar 10, 2015·4 cites·26 claims
- 0269US9556159B2Renin inhibitorMITSUBISHI TANABE PHARMA CORP·Filed 2013·Granted Jan 31, 2017·2 cites·10 claims
- 0367US11578074B2Nitrogenous heterocyclic compound, preparation method, intermediate, composition, and applicationSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2018·Granted Feb 14, 2023·1 cites·24 claims
- 0466US10828305B2Nitrogenous heterocyclic compound, preparation method, intermediate, composition and useSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2017·Granted Nov 10, 2020·1 cites·17 claims
- 0565US9278944B2Nitrogen-containing saturated heterocyclic compoundIIJIMA TORU·Filed 2012·Granted Mar 8, 2016·1 cites·21 claims
- 0664US10519150B2Salts of morpholine derivative, crystal forms thereof, processes for producing the same, pharmaceutical compositions including the same, and use thereofSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2016·Granted Dec 31, 2019·1 cites·16 claims
- 0760US10988476B2Substituted pyrimidines as cyclin-dependent kinase inhibitorsSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2020·Granted Apr 27, 2021·0 cites·18 claims
- 0856US10870627B2Salt of quinazoline derivative, preparation method therefor and application thereofSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2017·Granted Dec 22, 2020·0 cites·12 claims
- 0955US2023398123A1Methods to treat inflammatory bowel diseaseSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2021·Application pending·0 cites
- 1052US2024317686A1RORyT MODULATOR, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOFSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2021·Application pending·0 cites
- 1151US10662186B2Substituted pyrimidines as cyclin-dependent kinase inhibitorsSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2016·Granted May 26, 2020·0 cites·4 claims
- 1251US2024116925A1Salt of nitrogen-containing fused heterocyclic compound or crystal form thereof, and preparation method therefor, pharmaceutical composition thereof, and use thereofSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2022·Application pending·0 cites
- 1351US2025197424A1Quinoline compound and use thereofSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2023·Application pending·0 cites
- 1451US2024197737A1Application of compound in preparation of inhibitory drug targeting erbb2 mutantSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2022·Application pending·0 cites
- 1551US2023330093A1Application of nitrogen-containing saturated heterocyclic compoundSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2021·Application pending·0 cites
- 1651US2025163053A1Crystalline form of nitrogen-containing heterocyclic compound, preparation method therefor and use thereofSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2023·Application pending·0 cites
- 1751US2024262793A1Quinazoline compound, and preparation method therefor and application thereofSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2022·Application pending·0 cites
- 1849US2022380433A1Tmem59 protein dimer or chimeric expression receptor improving t cell functionSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2020·Application pending·0 cites
- 1948US2023365563A1Quinazoline compound and application thereofSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2021·Application pending·0 cites
- 2048US2023028539A1Pharmaceutical composition, complementary kit and application thereofSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2020·Application pending·0 cites
- 2147US10155731B2Nitrogen-containing saturated heterocyclic compoundMITSUBISHI TANABE PHARMA CORP·Filed 2016·Granted Dec 18, 2018·0 cites·3 claims
- 2247US2022324868A1Pyrazolone-Fused Pyrimidine Compound, and Preparation Method and Use ThereforSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2020·Application pending·0 cites
- 2346US2024101552A1Carbonyl heterocyclic compound and application thereofSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2021·Application pending·0 cites
- 2445US2022259210A1Pyrazolone-Fused Pyrimidine Compound, Preparation Method for Same and Applications ThereofSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2020·Application pending·0 cites
- 2545US2022195397A1Immune cell containing tumor antigen recognition receptor and application thereofSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2020·Application pending·0 cites
- 2642US2022048915A1Nitrogen-containing Heterocyclic Compound and Composition Thereof, Preparation Method Therefor, and Application ThereofSHANGHAI PHARMACEUTICALS HOLDING CO LTD·Filed 2019·Application pending·0 cites
- 2740US2006148866A1Novel process for preparing pramipexole and its optical isomeric mixture by reduction with sodium triacetoxyborohydrideCHEMAGIS LTD·Filed 2005·Application pending·0 cites
- 2826US9371292B2Quinazoline derivative, preparation method therefor, intermediate, composition and application thereofXIA GUANGXIN·Filed 2012·Granted Jun 21, 2016·0 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when Guangxin Xia files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →